A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer

Clinical trial NCT03100955 · UNKNOWN

Trial details

NCT number: NCT03100955
Sponsor: Qingdao University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Progression Free Survival

Start date: 2017-03-01
Primary completion: 2019-02-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.